| UniProt ID | PNMA2_HUMAN | |
|---|---|---|
| UniProt AC | Q9UL42 | |
| Protein Name | Paraneoplastic antigen Ma2 | |
| Gene Name | PNMA2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 364 | |
| Subcellular Localization | Nucleus, nucleolus . | |
| Protein Description | ||
| Protein Sequence | MALALLEDWCRIMSVDEQKSLMVTGIPADFEEAEIQEVLQETLKSLGRYRLLGKIFRKQENANAVLLELLEDTDVSAIPSEVQGKGGVWKVIFKTPNQDTEFLERLNLFLEKEGQTVSGMFRALGQEGVSPATVPCISPELLAHLLGQAMAHAPQPLLPMRYRKLRVFSGSAVPAPEEESFEVWLEQATEIVKEWPVTEAEKKRWLAESLRGPALDLMHIVQADNPSISVEECLEAFKQVFGSLESRRTAQVRYLKTYQEEGEKVSAYVLRLETLLRRAVEKRAIPRRIADQVRLEQVMAGATLNQMLWCRLRELKDQGPPPSFLELMKVIREEEEEEASFENESIEEPEERDGYGRWNHEGDD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MALALLEDW ------CHHHHHHHH | 11.09 | - | |
| 54 | Ubiquitination | GRYRLLGKIFRKQEN CHHHHHHHHHHCHHC | 38.34 | 21890473 | |
| 54 | Ubiquitination | GRYRLLGKIFRKQEN CHHHHHHHHHHCHHC | 38.34 | 21890473 | |
| 58 | Ubiquitination | LLGKIFRKQENANAV HHHHHHHCHHCCCHH | 51.74 | - | |
| 85 | Ubiquitination | IPSEVQGKGGVWKVI CCHHHCCCCCEEEEE | 35.09 | - | |
| 94 | Ubiquitination | GVWKVIFKTPNQDTE CEEEEEEECCCCCHH | 52.53 | - | |
| 112 | Ubiquitination | RLNLFLEKEGQTVSG HHHHHHHHCCCCHHH | 70.10 | - | |
| 118 | Phosphorylation | EKEGQTVSGMFRALG HHCCCCHHHHHHHHC | 28.11 | 22199227 | |
| 256 | Ubiquitination | TAQVRYLKTYQEEGE HHHHEEEEHHHHHCC | 35.93 | 21890473 | |
| 256 | Ubiquitination | TAQVRYLKTYQEEGE HHHHEEEEHHHHHCC | 35.93 | 21890473 | |
| 264 | Ubiquitination | TYQEEGEKVSAYVLR HHHHHCCHHHHHHHH | 52.96 | - | |
| 274 | Phosphorylation | AYVLRLETLLRRAVE HHHHHHHHHHHHHHH | 35.37 | 23312004 | |
| 316 | Ubiquitination | WCRLRELKDQGPPPS HHHHHHHHHCCCCCC | 43.16 | 21890473 | |
| 316 | Ubiquitination | WCRLRELKDQGPPPS HHHHHHHHHCCCCCC | 43.16 | 21890473 | |
| 323 | Phosphorylation | KDQGPPPSFLELMKV HHCCCCCCHHHHHHH | 48.51 | - | |
| 329 | Ubiquitination | PSFLELMKVIREEEE CCHHHHHHHHHHHHH | 47.32 | 21890473 | |
| 329 | Ubiquitination | PSFLELMKVIREEEE CCHHHHHHHHHHHHH | 47.32 | 21890473 | |
| 340 | Phosphorylation | EEEEEEASFENESIE HHHHHHHCCCCCCCC | 36.05 | 26471730 | |
| 345 | Phosphorylation | EASFENESIEEPEER HHCCCCCCCCCCHHC | 47.05 | 22912867 | |
| 355 | Phosphorylation | EPEERDGYGRWNHEG CCHHCCCCCCCCCCC | 14.06 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PNMA2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PNMA2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PNMA2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| C43BP_HUMAN | COL4A3BP | physical | 22863883 | |
| PRP31_HUMAN | PRPF31 | physical | 25416956 | |
| CBX8_HUMAN | CBX8 | physical | 25416956 | |
| SCNM1_HUMAN | SCNM1 | physical | 25416956 | |
| CCD33_HUMAN | CCDC33 | physical | 25416956 | |
| ENKD1_HUMAN | ENKD1 | physical | 25416956 | |
| F161A_HUMAN | FAM161A | physical | 25416956 | |
| ZN587_HUMAN | ZNF587 | physical | 25416956 | |
| LLR1_HUMAN | LRR1 | physical | 25416956 | |
| ZN417_HUMAN | ZNF417 | physical | 25416956 | |
| TTL10_HUMAN | TTLL10 | physical | 25416956 | |
| RTP5_HUMAN | RTP5 | physical | 25416956 | |
| ZN417_HUMAN | ZNF417 | physical | 21516116 | |
| ENKD1_HUMAN | ENKD1 | physical | 21516116 | |
| RNF8_HUMAN | RNF8 | physical | 21516116 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...